Gavrilova N I, Putyshev A B, Korolenko T A
Biull Eksp Biol Med. 1982 Jul;94(7):58-60.
Three-fold administration of polyvinylpyrrolidone (PVP), molecular weight 24 000, in a dose of 3.3 ml of 0.6% solution per 100 g/bw to rats was accompanied by disorders of lysosomal integrity and increased vulnerability to damage of the particles in the hypotonic medium (as judged from acid ribonuclease and cathepside D release). Five days after a single administration 125I-PVP was retained primarily by liver cells (7.3% of the dose administered) and to a lesser degree by renal cells (0.43%) and spleen cells (0.93%). Ninety per cent of the labeled PVP was bound to granular fractions of the rat liver (pinosomes, heterolysosomes). In the course of particles destruction by 0.1% Triton X-100 90% of 125I-PVP was released into the supernatant, which confirms the lysosomal localization of the compound.
给大鼠按每100克体重注射3.3毫升0.6%的分子量为24000的聚乙烯吡咯烷酮(PVP),分三次给药,会伴随溶酶体完整性紊乱以及在低渗介质中颗粒对损伤的易感性增加(根据酸性核糖核酸酶和组织蛋白酶D的释放判断)。单次给药五天后,125I - PVP主要被肝细胞保留(占给药剂量的7.3%),被肾细胞(0.43%)和脾细胞(0.93%)保留的程度较低。90%的标记PVP与大鼠肝脏的颗粒部分(吞噬体、异溶酶体)结合。在0.1% Triton X - 100破坏颗粒的过程中,90%的125I - PVP释放到上清液中,这证实了该化合物的溶酶体定位。